Metraipolis › archive › dc_2ccf73eafc21

Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis — Europe PMC PMID:41868651

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41868651
DOI
10.3389/falgy.2026.1766647
License (as archived)
solo-consultazione
Archived
2026-11-05T02:21:39.977Z
SHA-256 of the archived text
72d364f235074666b1856ce76a19d487862eef901cdbbb9599ec3b86afac433a
Stable URL of this page
https://metraipolis.com/documento/dc_2ccf73eafc21

How to cite

Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis — Europe PMC PMID:41868651 — Europe PMC (en), https://europepmc.org/article/MED/41868651 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ccf73eafc21 (Metraipolis archive dc_2ccf73eafc21, sha256 72d364f235074666b1856ce76a19d487862eef901cdbbb9599ec3b86afac433a)
BibTeX
@misc{dc2ccf73eafc21,
  title = {Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis — Europe PMC PMID:41868651},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41868651},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ccf73eafc21; sha256 72d364f235074666b1856ce76a19d487862eef901cdbbb9599ec3b86afac433a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41868651. Agents can read the archived copy with the MCP tool read_document.